ARTICLE | Clinical News
Denosumab regulatory update
March 26, 2012 7:00 AM UTC
Daiichi Sankyo said it submitted a regulatory application in Japan for denosumab to treat osteoporosis. The human mAb targeting receptor activator of NF-kappa B ligand ( RANKL) is approved in Japan a...